MediNotes Acquisition to Open Doors to Physician Practices


By Neil Versel, contributing editor

Sept. 30, 2008 | With its recently announced plans to take over MediNotes (West Des Moines, Iowa), Atlanta-based hospital systems vendor Eclipsys is making a push into the fast-growing but hard-to-reach market for independent physician practices.

“Our health-system clients have been asking us for an integrated solution with practice management and clinical to ‘gift’ or to recommend to small practices,” says Jay Deady, Eclipsys executive vice president for client solutions. Although Eclipsys claims 2,000 physician users of its Sunrise Ambulatory Care electronic medical record (EMR) software, Deady says the main sales channel is through integrated health systems with high-acuity service lines.

“We have a very segmented coverage model,” according to Deady. “Downsizing Sunrise Ambulatory was not a viable option.”

Seeking to close the gap in its product line, Eclipsys reached an agreement Sept. 19 to purchase privately held MediNotes for $45 million in cash and stock. (See “Deals, Deployments, and Short News,” Sept. 30.) Deady says his company was attracted to MediNotes for its product capability, natively integrated clinical, financial, and supply-chain management components, and the management team, headed by president and CEO Donald Schoen and Travis Bond, the chief strategy officer and executive senior vice president of business development at MediNotes.

Deady says Schoen and Bond will stay on to run MediNotes as a wholly owned subsidiary of Eclipsys, but that the parent company likely will re-brand MediNotes products. Bond joined MediNotes in February when that company acquired Bond Technologies. (See “Deals, Deployments, and Short News,” Feb. 26.)

The dedicated MediNotes sales force, targeting practices with more than five physicians, will report to Schoen. The MediNotes chief also will manage sales efforts aimed at solo practices and very small groups through a network of value-added resellers.

Before the end of the year, Deady hopes to have Health Level Seven messaging links between Eclipsys and MediNotes EMRs. By early spring, interoperability will expand to include additional, unspecified data elements, in preparation for a “deep interoperable stage” the company hopes to reach by early 2010. Deady says he expects the products to exceed the 2009 interoperability standards set by the Certification Commission for Healthcare Information Technology (CCHIT).

Deady says Eclipsys will detail this three-stage integration and development plan at a user’s group meeting next week in Atlanta.

Schoen says most of the integration, as well as ongoing development and CCHIT certification, will take place with MediNotes Clinician, the former Bond Technologies product that includes both EMR and practice management functions. “We believe the whole market is moving toward a suite scenario,” Schoen tells Digital HealthCare & Productivity.

However, there are no immediate plans to discontinue MediNotes e, a stand-alone EMR. Schoen says the company has four years of sales commitments to the e product.

Click here to log in.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

thomson reuters image
Biomarkers: An Indispensible Addition to the Drug Development Toolkit
Examining the Potential of Biomarkers
Sponsored by Thomson Reuters

Biomarkers are becoming an essential part of clinical development. In this white paper, Thomson Reuters provides insight from experts in industry and academia, and explores the role of biomarkers as evaluative tools in improving clinical research and the challenges this presents.

Discover the potential of biomarkers to:

  • Improve decision making
  • Accelerate drug development
  • Reduce development costs


BlueArc_Scientific Data
Scientific Data Lifecycle Management: Preparing for Storage in an Uncertain Future
Sponsored by BlueArc

Managing vast and overwhelming streams of gene sequencing data today requires ultra-high performance systems and processes. With continued rapid advancement and improvements in gene sequencing, expect tomorrow’s instruments to output quantities of genomic information that will dwarf current levels. Help your organization maintain data control and prepare for the future of sequencing through this informative paper that discusses:

  • The information technology challenges of gene sequencing
  • “Intelligent” methods for data management and customization
  • System survival tips... Deciding what data to keep or delete
  • New tools to keep scientists ahead of impending data torrents


SAS Managed image
Managed Innovation, Assured Compliance
Developing, executing and managing the transformation, analysis and submission of clinical research data with SAS® Drug Development
Sponsored by SAS
Get better products to market faster. Download this white paper to discover the top ten challenges facing life science executives and how to overcome them. See how SAS Drug Development transforms clinical data into true innovation.


Life Science Webcasts & Podcasts

Presented by Trade Commission of Spain

Spain Biotech: An Engine for Economic Change 

TCS podcastDiscover how Spain is focusing on biotechnology to be an engine for economic change through gradual internationalization, development and technology transfer.

Regional governments are actively investing in public and private biology research and promoting the creation of knowledge-based companies. Spain’s human capital combined with aggressive investment in biotech research and infrastructure has led to the creation of bio-clusters.

Today, there are nearly 700 Spanish companies engaged in biotechnology, with almost 50 percent growth in funding devoted to research. In fact, spending on internal R & D in biotechnology has grown 46 percent and is close to 300 million Euros.

Access the podcast 

 



More Podcasts

Job Openings

saic_logo

MANAGER, SCIENTIFIC COMPUTING & PROGRAMMING
(Bioinformatics Manager)
SAIC-Frederick, Inc has an exciting opportunity for a Manager, Scientific Computing & Programming - Core Genoytyping Facility in Gaithersburg, Maryland.  In this role, you will lead the Bioinformatics & Analysis Group.
Master’s or equivalent required.  PhD preferred. Six years experience in development of scientific programs in high-performance computing environment including five years supporting scientific research in computational chemistry, biology, or genetics, & two years supervisory experience.  View complete job posting & apply: www.saic-frederick.com. Position #146945.

For reprints and/or copyright permission, please contact The YGS Group, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.